Smith & Nephew (LON:SN) Insider Acquires £101,668 in Stock

Smith & Nephew plc (LON:SN) insider David King purchased 2,800 shares of Smith & Nephew stock in a transaction that occurred on Monday, August 18th. The stock was bought at an average cost of GBX 3,631 per share, with a total value of £101,668.

Smith & Nephew Stock Performance

Shares of SN opened at GBX 1,383 on Friday. The firm has a market capitalization of £15.16 billion, a P/E ratio of 49.79, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The business’s fifty day simple moving average is GBX 1,180.15 and its 200-day simple moving average is GBX 1,102.83. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Berenberg Bank increased their target price on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a “hold” rating in a report on Thursday, August 7th. JPMorgan Chase & Co. increased their target price on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an “overweight” rating in a report on Wednesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a “hold” rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of GBX 1,379.33.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.